The U.S. Food and Drug Administration today approved Kresladi (marnetegragene autotemcel), the first gene therapy for the treatment of severe Leukocyte Adhesion Deficiency Type I (LAD-I).
via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/P6gHXdE
No comments:
Post a Comment